Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

9 Nov 2017

Abstract excerpt

BACKGROUND: Minimally invasive specific biomarkers of neurodegenerative diseases (NDs) would facilitate patient selection and disease progression monitoring. We describe the assessment of circulating brain-enriched microRNAs as potential biomarkers for Alzheimer's disease (AD), frontotemporal dementia (FTD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). METHODS: In this case-control study,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to MicroRNA in disease regulation
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29121998
DOI: 10.1186/s13195-017-0316-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesPMID 29121998Read ↗

MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.Semantic proximity Read ↗

A blood based 12-miRNA signature of Alzheimer disease patientsSemantic proximity Read ↗

Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's DiseaseSemantic proximity Read ↗

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative DiseasesSemantic proximity Read ↗

Machine learning to detect Alzheimer’s disease from circulating non-coding RNAsSemantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)Semantic proximity Read ↗

microRNA-150-5p: A Novel Blood-Based Biomarker for Alzheimer’s Dementia with Good Correlation to Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral AtrophySemantic proximity Read ↗

Plasma microRNA biomarkers for detection of mild cognitive impairmentSemantic proximity Read ↗

Plasma microRNAs as potential biomarkers in early Alzheimer disease expressionSemantic proximity Read ↗

MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive reviewSemantic proximity Read ↗

Rethinking Alzheimer’s: Novel miRNAs Illuminate a Disease Beyond the BrainSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.